Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qumra Capital is an Israeli late-stage venture capital and growth equity firm focused on backing rapidly growing technology companies. The firm is not a biotech, pharma, or healthcare operating company; rather, it invests across technology sectors and has included some healthcare and digital health companies within its portfolio. Qumra Capital describes itself as focused on the Israeli growth market and on companies with proven market fit and significant revenue. Its business is investment management, portfolio support, and scaling companies toward global leadership rather than developing therapeutic products or healthcare services directly.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qumra Capital.